Home › NDC Lookup › RxCUI directory › RxCUI 2003767

1.14 ML sarilumab 175 MG/ML Auto-Injector [Kevzara] — RxCUI 2003767

RxNorm drug concept · Semantic branded drug
RxCUI 2003767 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2003767
Official name1.14 ML sarilumab 175 MG/ML Auto-Injector [Kevzara]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1.14 ML Kevzara 175 MG/ML Auto-Injector; KEVZARA 200 MG in 1.14 mL Auto-Injector; Kevzara 200 MG per 1.14 ML Auto-Injector
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)5,765 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sarilumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Kevzara targets a specific protein called IL-6 that drives inflammation in your joints and body. Unlike traditional DMARDs (like methotrexate), which work more broadly, Kevzara zer...
  • What exactly is Kevzara treating — and how is it different from other arthritis medicines?
  • You'll use a pre-filled syringe or pre-filled pen, injecting it under the skin — usually in the belly, thigh, or upper arm. Before injecting, let the pre-filled syringe sit at room...
  • How do I give myself this injection at home?
📖 Read our full Sarilumab Injection guide →

🕸️ Concept Web — How 1.14 ML sarilumab 175 MG/ML Auto-Injector [Kevza... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1.14 ML sarilumab 175 MG/ML Auto-Injector [Kevzara] RxCUI 2003767

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sarilumab 1923319
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Kevzara 1923334
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sarilumab Auto-Injector 2003754
    • Sarilumab Injectable Product 1923331
    • Sarilumab Auto-Injector [Kevzara] 2003756
    • Kevzara Injectable Product 1923337
    • Auto-Injector 1649570
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Sarilumab 175 MG/ML [Kevzara] SBDC · 1923346
  • Sarilumab Auto-Injector [Kevzara] SBDF · 2003756
  • Kevzara Injectable Product SBDG · 1923337
  • Kevzara BN · 1923334

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 2003767 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00024-5908-01 2 SYRINGE in 1 PACKAGE (0024-5908-01) / 1.14 mL in 1 SYRING... KEVZARA Sanofi-Aventis U.S. LLC 2017-05-22
00024-5908-02 2 SYRINGE in 1 PACKAGE (0024-5908-02) / 1.14 mL in 1 SYRING... KEVZARA Sanofi-Aventis U.S. LLC 2017-05-22
00024-5910-01 2 SYRINGE in 1 PACKAGE (0024-5910-01) / 1.14 mL in 1 SYRING... KEVZARA Sanofi-Aventis U.S. LLC 2017-05-22
00024-5910-02 2 SYRINGE in 1 PACKAGE (0024-5910-02) / 1.14 mL in 1 SYRING... KEVZARA Sanofi-Aventis U.S. LLC 2017-05-22
00024-5920-01 2 SYRINGE in 1 PACKAGE (0024-5920-01) / 1.14 mL in 1 SYRING... KEVZARA Sanofi-Aventis U.S. LLC 2018-04-13
00024-5920-02 2 SYRINGE in 1 PACKAGE (0024-5920-02) / 1.14 mL in 1 SYRING... KEVZARA Sanofi-Aventis U.S. LLC 2018-04-13
00024-5922-01 2 SYRINGE in 1 PACKAGE (0024-5922-01) / 1.14 mL in 1 SYRING... KEVZARA Sanofi-Aventis U.S. LLC 2018-04-13
00024-5922-02 2 SYRINGE in 1 PACKAGE (0024-5922-02) / 1.14 mL in 1 SYRING... KEVZARA Sanofi-Aventis U.S. LLC 2018-04-13
Observed labelers: Sanofi-Aventis U.S. LLC (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.